Switch to:
Also traded in: Brazil, Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.07
CVS's Cash to Debt is ranked lower than
88% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. CVS: 0.07 )
Ranked among companies with meaningful Cash to Debt only.
CVS' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.14 Max: 1.14
Current: 0.07
0.06
1.14
Equity to Asset 0.39
CVS's Equity to Asset is ranked higher than
65% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. CVS: 0.39 )
Ranked among companies with meaningful Equity to Asset only.
CVS' s Equity to Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.54 Max: 0.67
Current: 0.39
0.39
0.67
Interest Coverage 9.41
CVS's Interest Coverage is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.42 vs. CVS: 9.41 )
Ranked among companies with meaningful Interest Coverage only.
CVS' s Interest Coverage Range Over the Past 10 Years
Min: 10.24  Med: 11.66 Max: 15.55
Current: 9.41
10.24
15.55
F-Score: 6
Z-Score: 3.74
M-Score: -2.45
WACC vs ROIC
7.88%
10.20%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 5.93
CVS's Operating margin (%) is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.20 vs. CVS: 5.93 )
Ranked among companies with meaningful Operating margin (%) only.
CVS' s Operating margin (%) Range Over the Past 10 Years
Min: 5.57  Med: 6.30 Max: 6.91
Current: 5.93
5.57
6.91
Net-margin (%) 3.22
CVS's Net-margin (%) is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.42 vs. CVS: 3.22 )
Ranked among companies with meaningful Net-margin (%) only.
CVS' s Net-margin (%) Range Over the Past 10 Years
Min: 3.12  Med: 3.44 Max: 3.74
Current: 3.22
3.12
3.74
ROE (%) 13.97
CVS's ROE (%) is ranked higher than
62% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. CVS: 13.97 )
Ranked among companies with meaningful ROE (%) only.
CVS' s ROE (%) Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.85
Current: 13.97
9.14
14.85
ROA (%) 6.04
CVS's ROA (%) is ranked higher than
81% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.92 vs. CVS: 6.04 )
Ranked among companies with meaningful ROA (%) only.
CVS' s ROA (%) Range Over the Past 10 Years
Min: 5.46  Med: 6.14 Max: 7.64
Current: 6.04
5.46
7.64
ROC (Joel Greenblatt) (%) 63.13
CVS's ROC (Joel Greenblatt) (%) is ranked lower than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 104.17 vs. CVS: 63.13 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CVS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 26.97  Med: 47.54 Max: 62.63
Current: 63.13
26.97
62.63
Revenue Growth (3Y)(%) 12.30
CVS's Revenue Growth (3Y)(%) is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.10 vs. CVS: 12.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CVS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 8  Med: 12.20 Max: 19.2
Current: 12.3
8
19.2
EBITDA Growth (3Y)(%) 15.10
CVS's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.20 vs. CVS: 15.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CVS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.1  Med: 14.20 Max: 47.7
Current: 15.1
2.1
47.7
EPS Growth (3Y)(%) 15.10
CVS's EPS Growth (3Y)(%) is ranked higher than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.80 vs. CVS: 15.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CVS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.1  Med: 15.10 Max: 194.7
Current: 15.1
-0.1
194.7
» CVS's 10-Y Financials

Financials (Next Earnings Date: 2016-08-02)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

CVS Guru Trades in Q2 2015

Louis Moore Bacon 50,000 sh (New)
Steven Cohen 34,300 sh (New)
Jeremy Grantham 2,058,725 sh (+96.25%)
RS Investment Management 681,410 sh (+42.54%)
Barrow, Hanley, Mewhinney & Strauss 389,950 sh (+27.87%)
PRIMECAP Management 3,602,710 sh (+9.04%)
Tom Gayner 247,000 sh (+0.82%)
Pioneer Investments 5,490,251 sh (+0.80%)
Richard Pzena 527,265 sh (+0.02%)
Charles de Vaulx 915,821 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
Robert Olstein 57,000 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Vanguard Health Care Fund 3,899,920 sh (unchged)
Steven Romick 4,146,600 sh (unchged)
Caxton Associates Sold Out
First Pacific Advisors 4,621,500 sh (-0.17%)
Jeff Auxier 95,649 sh (-0.36%)
Scott Black 99,462 sh (-0.85%)
John Rogers 82,895 sh (-1.43%)
Ken Fisher 156,437 sh (-1.60%)
Mario Gabelli 1,359,978 sh (-5.44%)
NWQ Managers 819,859 sh (-30.15%)
Manning & Napier Advisors, Inc 88,230 sh (-37.43%)
Joel Greenblatt 91,217 sh (-66.50%)
Paul Tudor Jones 3,200 sh (-96.62%)
» More
Q3 2015

CVS Guru Trades in Q3 2015

Jim Simons 854,505 sh (New)
John Burbank 30,304 sh (New)
Mairs and Power 2,246 sh (New)
Louis Moore Bacon 123,000 sh (+146.00%)
Jeremy Grantham 2,397,897 sh (+16.47%)
RS Investment Management 714,365 sh (+4.84%)
Richard Pzena 527,265 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
Steven Cohen Sold Out
John Rogers Sold Out
Barrow, Hanley, Mewhinney & Strauss 383,650 sh (-1.62%)
Manning & Napier Advisors, Inc 85,900 sh (-2.64%)
Signature Select Canadian Fund 72,453 sh (-4.36%)
NWQ Managers 783,473 sh (-4.44%)
PRIMECAP Management 3,408,820 sh (-5.38%)
Charles de Vaulx 840,664 sh (-8.21%)
Scott Black 89,505 sh (-10.01%)
Mario Gabelli 1,215,593 sh (-10.62%)
Pioneer Investments 4,893,987 sh (-10.86%)
Paul Tudor Jones 2,600 sh (-18.75%)
Vanguard Health Care Fund 3,084,020 sh (-20.92%)
Robert Olstein 45,000 sh (-21.05%)
Ken Fisher 122,805 sh (-21.50%)
Jeff Auxier 52,499 sh (-45.11%)
Joel Greenblatt 20,797 sh (-77.20%)
First Pacific Advisors 681,570 sh (-85.25%)
Steven Romick 507,110 sh (-87.77%)
» More
Q4 2015

CVS Guru Trades in Q4 2015

Ray Dalio 83,137 sh (New)
George Soros 25,971 sh (New)
Paul Tudor Jones 8,633 sh (+232.04%)
Mairs and Power 3,819 sh (+70.04%)
Robert Olstein 64,000 sh (+42.22%)
RS Investment Management 788,185 sh (+10.33%)
PRIMECAP Management 3,545,070 sh (+4.00%)
Pioneer Investments 5,082,510 sh (+3.85%)
Manning & Napier Advisors, Inc 86,300 sh (+0.47%)
Richard Pzena 527,389 sh (+0.02%)
Tom Gayner 247,000 sh (unchged)
Jeff Auxier 52,499 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Charles de Vaulx 840,664 sh (unchged)
Vanguard Health Care Fund 3,084,020 sh (unchged)
Steven Romick Sold Out
Jim Simons Sold Out
Joel Greenblatt Sold Out
John Burbank Sold Out
Louis Moore Bacon Sold Out
Ken Fisher 122,308 sh (-0.40%)
NWQ Managers 760,638 sh (-2.91%)
Mario Gabelli 1,178,788 sh (-3.03%)
Barrow, Hanley, Mewhinney & Strauss 368,897 sh (-3.85%)
Jeremy Grantham 2,300,997 sh (-4.04%)
Ruane Cunniff 18,153 sh (-27.25%)
Scott Black 19,044 sh (-78.72%)
First Pacific Advisors 127,300 sh (-81.32%)
» More
Q1 2016

CVS Guru Trades in Q1 2016

Dodge & Cox 2,630 sh (New)
Joel Greenblatt 220,252 sh (New)
Steven Cohen 115,300 sh (New)
Murray Stahl 3,090 sh (New)
Jim Simons 195,105 sh (New)
Ken Fisher 142,324 sh (+16.37%)
George Soros 27,511 sh (+5.93%)
Pioneer Investments 5,363,313 sh (+5.52%)
Manning & Napier Advisors, Inc 87,090 sh (+0.92%)
Mario Gabelli 1,188,900 sh (+0.86%)
Jeremy Grantham 2,319,096 sh (+0.79%)
RS Investment Management 792,755 sh (+0.58%)
Richard Pzena 528,659 sh (+0.24%)
PRIMECAP Management 3,548,780 sh (+0.10%)
Paul Tudor Jones 47,500 sh (unchged)
Robert Olstein 64,000 sh (unchged)
Paul Tudor Jones 50,200 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Vanguard Health Care Fund Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Paul Tudor Jones Sold Out
Ray Dalio Sold Out
Jeff Auxier 52,349 sh (-0.29%)
Signature Select Canadian Fund 70,053 sh (-3.31%)
Scott Black 18,149 sh (-4.70%)
NWQ Managers 707,549 sh (-6.98%)
Charles de Vaulx 778,764 sh (-7.36%)
Ruane Cunniff 15,981 sh (-11.96%)
First Pacific Advisors 106,140 sh (-16.62%)
Mairs and Power 3,069 sh (-19.64%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:NYSE:UNH, NAS:ESRX, NYSE:AET, NYSE:ANTM, NYSE:CI, NYSE:HUM, NYSE:CNC, NYSE:HNT, NYSE:WCG, NYSE:MOH, OTCPK:ODPVY, NAS:MGLN, OTCPK:QUAIF, NYSE:UAM, NAS:CNXR, NAS:HIIQ, OTCPK:OPRX, OTCPK:WCUI » details
Traded in other countries:CVSH34.Brazil, CVS.Chile, CVS.Germany, CVS.Mexico,
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. The Company is an integrated pharmacy health care provider in the United States. It has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The pharmacy services segment provides pharmacy benefit management services to their clients consisting of employers, insurance companies, unions, government employee groups, managed care organizations ("MCOs") and other sponsors of health benefit plans and individuals throughout the United States. The Company operates a network of mail service specialty pharmacies. There specialty pharmacies were comprised of 11 specialty mail order pharmacies located throughout the United States that are used for delivery of medications to individuals with chronic or genetic diseases and disorders. The retail pharmacy segment included 7,660 retail drugstores, of which 7,603 operated a pharmacy, their online retail pharmacy websites, CVS.com and Onofre.com.br, 17 onsite pharmacy stores and retail health care clinics. There corporate segment provides management and administrative services to support the operations of the company. The corporate Segment consists of certain aspects of executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. Its customers include managed care organizations and government-funded health care commercial employers. It competes with other drugstore chains like Walgreens and Rite Aid, supermarkets, discount retailers (e.g., Wal-Mart and Target), independent pharmacies, restrictive pharmacy networks, membership clubs, Internet companies and retail health clinics, as well as other mail order pharmacies and PBMs. The Company's business is subject to federal and state laws and regulations that govern the purchase, sale and distribution of prescription drugs and related services, including administration and management of prescription drug benefits.

Ratios

vs
industry
vs
history
P/E(ttm) 20.75
CVS's P/E(ttm) is ranked higher than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.87 vs. CVS: 20.75 )
Ranked among companies with meaningful P/E(ttm) only.
CVS' s P/E(ttm) Range Over the Past 10 Years
Min: 10.57  Med: 18.35 Max: 27.11
Current: 20.75
10.57
27.11
Forward P/E 16.26
CVS's Forward P/E is ranked higher than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.13 vs. CVS: 16.26 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 20.80
CVS's PE(NRI) is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.25 vs. CVS: 20.80 )
Ranked among companies with meaningful PE(NRI) only.
CVS' s PE(NRI) Range Over the Past 10 Years
Min: 10.58  Med: 18.34 Max: 27.1
Current: 20.8
10.58
27.1
Price/Owner Earnings (ttm) 15.59
CVS's Price/Owner Earnings (ttm) is ranked lower than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.92 vs. CVS: 15.59 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CVS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 9.33  Med: 21.07 Max: 60.4
Current: 15.59
9.33
60.4
P/B 2.89
CVS's P/B is ranked lower than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.58 vs. CVS: 2.89 )
Ranked among companies with meaningful P/B only.
CVS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 1.77 Max: 3.37
Current: 2.89
1.01
3.37
P/S 0.66
CVS's P/S is ranked lower than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.51 vs. CVS: 0.66 )
Ranked among companies with meaningful P/S only.
CVS' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 0.61 Max: 0.89
Current: 0.66
0.4
0.89
PFCF 16.98
CVS's PFCF is ranked lower than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.94 vs. CVS: 16.98 )
Ranked among companies with meaningful PFCF only.
CVS' s PFCF Range Over the Past 10 Years
Min: 9.12  Med: 21.84 Max: 211.81
Current: 16.98
9.12
211.81
POCF 12.14
CVS's POCF is ranked lower than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.59 vs. CVS: 12.14 )
Ranked among companies with meaningful POCF only.
CVS' s POCF Range Over the Past 10 Years
Min: 6.72  Med: 13.32 Max: 23.98
Current: 12.14
6.72
23.98
EV-to-EBIT 13.47
CVS's EV-to-EBIT is ranked lower than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.38 vs. CVS: 13.47 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.60 Max: 20.4
Current: 13.47
7.6
20.4
EV-to-EBITDA 10.95
CVS's EV-to-EBITDA is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.18 vs. CVS: 10.95 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.40 Max: 16
Current: 10.95
6.2
16
PEG 1.49
CVS's PEG is ranked lower than
57% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.21 vs. CVS: 1.49 )
Ranked among companies with meaningful PEG only.
CVS' s PEG Range Over the Past 10 Years
Min: 0.55  Med: 1.44 Max: 2.47
Current: 1.49
0.55
2.47
Shiller P/E 30.70
CVS's Shiller P/E is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.04 vs. CVS: 30.70 )
Ranked among companies with meaningful Shiller P/E only.
CVS' s Shiller P/E Range Over the Past 10 Years
Min: 17.19  Med: 26.52 Max: 39.47
Current: 30.7
17.19
39.47
Current Ratio 1.20
CVS's Current Ratio is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.32 vs. CVS: 1.20 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.51 Max: 2.09
Current: 1.2
1.05
2.09
Quick Ratio 0.63
CVS's Quick Ratio is ranked lower than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.30 vs. CVS: 0.63 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.58 Max: 0.93
Current: 0.63
0.29
0.93
Days Inventory 36.10
CVS's Days Inventory is ranked lower than
78% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.05 vs. CVS: 36.10 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 36.78  Med: 44.51 Max: 73.45
Current: 36.1
36.78
73.45
Days Sales Outstanding 29.68
CVS's Days Sales Outstanding is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.23 vs. CVS: 29.68 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.65  Med: 21.26 Max: 28.31
Current: 29.68
18.65
28.31
Days Payable 20.19
CVS's Days Payable is ranked lower than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 53.08 vs. CVS: 20.19 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.58  Med: 19.86 Max: 28.87
Current: 20.19
16.58
28.87

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.61
CVS's Dividend Yield is ranked higher than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.55 vs. CVS: 1.61 )
Ranked among companies with meaningful Dividend Yield only.
CVS' s Dividend Yield Range Over the Past 10 Years
Min: 0.42  Med: 1.09 Max: 1.66
Current: 1.61
0.42
1.66
Dividend Payout 0.32
CVS's Dividend Payout is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.28 vs. CVS: 0.32 )
Ranked among companies with meaningful Dividend Payout only.
CVS' s Dividend Payout Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 1.4
Current: 0.32
0.08
1.4
Dividend Growth (3y) 29.10
CVS's Dividend Growth (3y) is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.00 vs. CVS: 29.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CVS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -13.6  Med: 15.20 Max: 37
Current: 29.1
-13.6
37
Forward Dividend Yield 1.80
CVS's Forward Dividend Yield is ranked higher than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. CVS: 1.80 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 6.35
CVS's Yield on cost (5-Year) is ranked higher than
59% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.51 vs. CVS: 6.35 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CVS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.66  Med: 4.30 Max: 6.55
Current: 6.35
1.66
6.55
3-Year Average Share Buyback Ratio 3.70
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
85% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.20 vs. CVS: 3.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.5  Med: -0.30 Max: 4.7
Current: 3.7
-22.5
4.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.06
CVS's Price/Projected FCF is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. CVS: 1.06 )
Ranked among companies with meaningful Price/Projected FCF only.
CVS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.82  Med: 1.99 Max: 13.38
Current: 1.06
0.82
13.38
Price/DCF (Earnings Based) 1.27
CVS's Price/DCF (Earnings Based) is ranked lower than
56% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.18 vs. CVS: 1.27 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.10
CVS's Price/Median PS Value is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. CVS: 1.10 )
Ranked among companies with meaningful Price/Median PS Value only.
CVS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.00 Max: 2.35
Current: 1.1
0.5
2.35
Price/Peter Lynch Fair Value 1.45
CVS's Price/Peter Lynch Fair Value is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. CVS: 1.45 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CVS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.62  Med: 1.58 Max: 6.09
Current: 1.45
0.62
6.09
Earnings Yield (Greenblatt) (%) 7.46
CVS's Earnings Yield (Greenblatt) (%) is ranked higher than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.20 vs. CVS: 7.46 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CVS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.9  Med: 8.60 Max: 13.2
Current: 7.46
4.9
13.2
Forward Rate of Return (Yacktman) (%) 18.72
CVS's Forward Rate of Return (Yacktman) (%) is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.71 vs. CVS: 18.72 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CVS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.5  Med: 16.20 Max: 24.2
Current: 18.72
9.5
24.2

More Statistics

Revenue (TTM) (Mil) $160,174
EPS (TTM) $ 4.62
Beta0.96
Short Percentage of Float1.27%
52-Week Range $81.37 - 113.65
Shares Outstanding (Mil)1,074.02

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 180,836 194,951 205,669
EPS ($) 5.73 6.49 7.28
EPS w/o NRI ($) 5.73 6.49 7.28
EPS Growth Rate
(3Y to 5Y Estimate)
14.15%
» More Articles for NYSE:CVS

Headlines

Articles On GuruFocus.com
Stocks Manning & Napier Continues Buying Jun 14 2016 
Pioneer Investments Adds to Stake in CVS May 12 2016 
High Quality Guru Stocks Include TransDigm, Chipotle May 03 2016 
Louis Moore Bacon Sells JPMorgan, Pfizer Mar 25 2016 
How Will Evolving Health Care Landscape Impact Walgreens? Mar 13 2016 
Is CVS Pharmacy Undervalued? Feb 22 2016 
Mario Gabelli Comments on CVS Health Corp Feb 05 2016 
Steven Romick Sells Microsoft, Walgreens, CVS Jan 20 2016 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
First Pacific Advisors Slashes Stake in CVS Health Dec 17 2015 

More From Other Websites
MinuteClinic Expands With New Walk-in Medical Clinics Inside South Florida Target Stores Jun 29 2016
Congressman Luján, NM Sec. of Health Gallagher, Santa Fe County Sheriff Garcia Join CVS Health To... Jun 29 2016
Moody's Affirms Four and Upgrades One Class of GMAC 1999-C2 Jun 23 2016
MinuteClinic Expands With New Walk-in Medical Clinics Inside South Florida Target Stores Jun 23 2016
CVS Pharmacy Now Open in Target Stores Throughout Colorado Jun 22 2016
CVS Health (CVS) Stock Rises, Deutsche Bank Drops Target Price Jun 22 2016
CVS: First No Cigarettes; Now More Paleo And Vegan Foods Jun 21 2016
Stocks Move Higher as 'Brexit' Vote Looms Jun 21 2016
MinuteClinic Expands With New Walk-in Medical Clinics Inside Dallas-Fort Worth Target Stores Jun 21 2016
CVS Pharmacy Expands Healthy Foods Initiative Jun 21 2016
MinuteClinic Expands With New Walk-in Medical Clinics Inside Dallas-Fort Worth Target Stores Jun 21 2016
Stock Futures Rise as Markets Prepare for Yellen Testimony Jun 21 2016
CVS Health to Support the OneOrlando Fund to Help Respond to the Needs of the Orlando Community Jun 21 2016
CVS will expand its healthier foods initiative to more than 2,900 stores Jun 21 2016
CVS Pharmacy Expands Healthy Foods Initiative Jun 21 2016
Here’s Why You’ll Likely Pay More for Your Employer-Sponsored Health Insurance Jun 21 2016
CVS’s stock drops after Morgan Stanley gives up on its bullish view Jun 20 2016
Trending Tickers: MRO, WMT, CVS, NKE Jun 20 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)